Pillar Invest Corp - Sep 22, 2022 Form 4 Insider Report for IDERA PHARMACEUTICALS, INC. (IDRA)

Role
10%+ Owner
Signature
Pillar Invest Corporation, /s/ Youssef El Zein, Authorized Person
Stock symbol
IDRA
Transactions as of
Sep 22, 2022
Transactions value $
$15,332
Form type
4
Date filed
9/26/2022, 04:32 PM
Next filing
Jul 19, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IDRA Common Stock Exercise of in-the-money or at-the-money derivative security $15.3K +1.53M +26.74% $0.01* 7.27M Sep 22, 2022 By Pillar Partners Foundation, L.P. See Footnotes F1, F2
holding IDRA Common Stock 2.3M Sep 22, 2022 By Pillar Pharmaceuticals 6, L.P. See Footnote F1
holding IDRA Common Stock 386K Sep 22, 2022 By Abude Umari See Footnote F1
holding IDRA Common Stock 26.3K Sep 22, 2022 By Youssef El Zein See Footnote F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IDRA Prefunded Warrants Exercise of in-the-money or at-the-money derivative security $0 -1.53M -50% $0.00 1.53M Sep 22, 2022 Common Stock 1.53M $0.01 By Pillar Partners Foundation, L.P. See Footnote F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Pillar Invest Corporation ("Pillar GP") is the general partner of Pillar Pharmaceuticals 6, L.P. ("Pillar 6") and Pillar Partners Foundation, L.P. ("Pillar Partners", together with Pillar GP and Pillar 6, the "Pillar Funds"). Youssef El Zein and Abude Umari are directors of Pillar GP. Each of Pillar GP, Mr. El Zein and Mr. Umari disclaims Section 16 beneficial ownership of the securities beneficially owned by the Pillar Funds and this report shall not be deemed an admission that any of Pillar GP, Mr. El Zein or Mr. Umari is the Section 16 beneficial owner of any such securities, except to the extent of its or his pecuniary interest therein, if any, by virtue of its or his ownership interest in the Pillar Funds or Pillar GP, as applicable.
F2 1,533,159 of such warrants beneficially owned and exercised for shares of common stock by Pillar Partners, of which Pillar GP is the general partner (the "Pillar Partners Warrants"). Pillar GP disclaims Section 16 beneficial ownership of the Pillar Partners Warrants and the common stock underlying such warrants and this report shall not be deemed an admission that Pillar GP is the Section 16 beneficial owner of any such securities, except to the extent of its pecuniary interest therein, if any, by virtue of its ownership interest in Pillar Partners Warrants.
F3 The Pre-funded Warrants have no expiration date.